2vx0
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
| - | {{Seed}} | ||
[[Image:2vx0.png|left|200px]] | [[Image:2vx0.png|left|200px]] | ||
| Line 14: | Line 13: | ||
<!-- | <!-- | ||
| - | The line below this paragraph, {{ | + | The line below this paragraph, {{ABSTRACT_PUBMED_18851911}}, adds the Publication Abstract to the page |
| - | (as it appears on PubMed at http://www.pubmed.gov), where | + | (as it appears on PubMed at http://www.pubmed.gov), where 18851911 is the PubMed ID number. |
--> | --> | ||
| - | {{ | + | {{ABSTRACT_PUBMED_18851911}} |
==About this Structure== | ==About this Structure== | ||
| - | + | [[2vx0]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2VX0 OCA]. | |
==Reference== | ==Reference== | ||
| - | <ref group="xtra">PMID:18434142</ref><references group="xtra"/> | + | <ref group="xtra">PMID:18851911</ref><ref group="xtra">PMID:18434142</ref><references group="xtra"/> |
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
[[Category: Receptor protein-tyrosine kinase]] | [[Category: Receptor protein-tyrosine kinase]] | ||
| Line 48: | Line 47: | ||
[[Category: Tyrosine-protein kinase]] | [[Category: Tyrosine-protein kinase]] | ||
[[Category: Unphosphorylated]] | [[Category: Unphosphorylated]] | ||
| - | |||
| - | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Feb 16 23:56:58 2009'' | ||
Revision as of 00:10, 15 March 2011
EPHB4 KINASE DOMAIN INHIBITOR COMPLEX
Template:ABSTRACT PUBMED 18851911
About this Structure
2vx0 is a 1 chain structure with sequence from Homo sapiens. Full crystallographic information is available from OCA.
Reference
- Bardelle C, Coleman T, Cross D, Davenport S, Kettle JG, Ko EJ, Leach AG, Mortlock A, Read J, Roberts NJ, Robins P, Williams EJ. Inhibitors of the tyrosine kinase EphB4. Part 2: structure-based discovery and optimisation of 3,5-bis substituted anilinopyrimidines. Bioorg Med Chem Lett. 2008 Nov 1;18(21):5717-21. Epub 2008 Sep 27. PMID:18851911 doi:10.1016/j.bmcl.2008.09.087
- Bardelle C, Cross D, Davenport S, Kettle JG, Ko EJ, Leach AG, Mortlock A, Read J, Roberts NJ, Robins P, Williams EJ. Inhibitors of the tyrosine kinase EphB4. Part 1: Structure-based design and optimization of a series of 2,4-bis-anilinopyrimidines. Bioorg Med Chem Lett. 2008 May 1;18(9):2776-80. Epub 2008 Apr 10. PMID:18434142 doi:10.1016/j.bmcl.2008.04.015
Categories: Homo sapiens | Receptor protein-tyrosine kinase | Barratt, D. | Brassington, C A. | Green, I. | Kettle, J G. | Leach, A G. | Mccall, E J. | Read, J. | Valentine, A L. | Atp-binding | Glycoprotein | Kinase | Membrane | Mutant | Nucleotide-binding | Phosphoprotein | Polymorphism | Receptor | Receptor tyrosine kinase | Transferase | Transmembrane | Tyrosine-protein kinase | Unphosphorylated
